It seems that in particular CD8+ T-cells with specificity for SSPQGSPEPL had protective potential, since in vivo cytotoxic activity correlated with both survival after lymphoma challenge and with increased frequency of multimer-binding cells. This evidence concerns the gene CD8A and lymphoma.